Sei Investments CO Ligand Pharmaceuticals Inc Transaction History
Sei Investments CO
- $75.3 Billion
- Q4 2024
A detailed history of Sei Investments CO transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Sei Investments CO holds 27,482 shares of LGND stock, worth $3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,482
Previous 26,805
2.53%
Holding current value
$3 Million
Previous $2.69 Million
9.65%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding LGND
# of Institutions
276Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$314 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$228 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$111 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$96.7 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$81.3 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.85B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...